Panel discussions
Last year more than 10 Swiss biotechs and 50 European biotechs raised a financing round above USD 50 million. What did they do right, what did they have to commit to, and what could they share about the experience? As in previous years, we will again look at financing developments and trends and what this means for companies looking to raise money in 2025 and beyond. Join us to hear from a panel of VCs, CEOs and industry experts.
May 6, 15:00-15:45, room Marriott 3+4+5
| Name | Position | Institution |
|---|---|---|
| Peter Mozerov | PhD, Senior Manager | KPMG AG |
| Name | Position | Institution |
|---|---|---|
| Patrik Frei | Founder and CEO at Venture Valuation AG | Venture Valuation AG |
KPMG is a leading professional services firm in Switzerland, noted for clear and consistent solutions in audit, tax and advisory. Through its strong regional presence KPMG is close to you, helping you navigate today’s turbulences to find tomorrow’s answers.. KPMG’s Life Sciences experts have a deep understanding of the industry to support companies in challenges around cost & efficiency, valuation & financing or regulatory compliance.
